Nonesterified fatty acids and endothelial dysfunction
Authors:
- 31 August 2003
- journal article
- Published by Elsevier in International Congress Series
- Vol. 1253, 139-145
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Insulin resistance in type 2 diabetes: role of fatty acidsDiabetes/Metabolism Research and Reviews, 2002
- PATHOGENESIS OF TYPE 2 DIABETESEndocrinology and Metabolism Clinics of North America, 2001
- Circulating Nonesterified Fatty Acid Level as a Predictive Risk Factor for Sudden Death in the PopulationCirculation, 2001
- Nonesterified fatty acids in blood pressure control and cardiovascular complicationsCurrent Hypertension Reports, 2001
- Free Fatty Acids and Pathogenesis of Type 2 Diabetes MellitusTrends in Endocrinology & Metabolism, 2000
- Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production.Diabetes, 2000
- Plasma Free Fatty Acids and Endothelium-Dependent Vasodilation: Effect of Chain-Length and Cyclooxygenase InhibitionThe Journal of Clinical Endocrinology & Metabolism, 2000
- Contribution Of Nitric Oxide, Cyclic Gmp And K+ Channels To Acetylcholine‐Induced Dilatation Of Rat Conduit And Resistance ArteriesClinical and Experimental Pharmacology and Physiology, 2000
- Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation.Journal of Clinical Investigation, 1997
- Arachidonic acid and free fatty acids as second messengers and the role of protein kinase CCellular Signalling, 1995